OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction

Journal of Clinical Pathology

Volumn 49, Issue 3, 1996, Pages 258-259

  Irving, J A E ^a   Cain, G ^a   Parr, A ^b   Howard, M ^c   Angus, B ^b   Cattan, A R ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b Department of Histopathology ^*

^c YORK HOSPITAL   (United Kingdom)

Author keywords

CD44; Cryostat sections; RNA; RT PCR

Indexed keywords

HERMES ANTIGEN; RNA;

ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TECHNIQUE;

EID: 0029881680     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.3.258     Document Type: Article

References (10)

1. East JA, Hart IR. CD44 and its role in tumour progression and metastasis. Eur J Cancer 1993;29A:1921-2.
2. Ruiz P, Schwärzler C, Günthert U. CD44 isoforms during differentiation and development. Bioessays 1995;17:17-24.
3. Screaton GR, Bell MV, Jackson DG, Cornelius FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-4.
4. Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994;124:71-82.
5. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340:1053-8.
6. Kaufmann M, Heider K-H, Sinn H-P, Von Minckwitz G, Ponta H, Herrlich P. CD44 variant epitopes in primary breast cancer and length of survival. Lancet 1995;345: 615-19.
7. Chirgwin JM, Przybyla AE, McDonald R, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
8. Cross NCP, Feng L, Bungey J, Goldman JM. Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction. Leuk Lymphoma 1993;11:39-43.
9. Cross NCP, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of bcr/abl fusion mRNAs in haematological disorders. Leukemia 1994;8:186-9.
10. Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v expression, a new prognostic factor in human breast cancer. Int J Cancer 1995;60:471-7.